Archive: August 2015
Feature Article
Managing Acquired Resistance in EGFR-Mutated Non–Small Cell Lung Cancer
Clinical Advances in Hematology & Oncology August 2015, Volume 13, Issue 8 Patrick M. Forde, MD, and David S. Ettinger, MD The authors are […]
Letter From the Editor
Letter From the Editor
Abstractions and Authorship Clinical Advances in Hematology & Oncology August 2015, Volume 13, Issue 8 August 4th, 2015 is the deadline for submission of […]
Feature Article
Hodgkin Lymphoma: Targeting the Tumor Microenvironment as a Therapeutic Strategy
Clinical Advances in Hematology & Oncology August 2015, Volume 13, Issue 8 Francesca Montanari, MD, and Catherine S. M. Diefenbach, MD The authors are affiliated […]
Melanoma in Focus
Neoadjuvant Therapy in Melanoma: The Fast Track to Critical New Answers
Clinical Advances in Hematology & Oncology August 2015, Volume 13, Issue 8 Ahmad A. Tarhini, MD, PhD Associate Professor of Medicine, Clinical, and Translational Science […]
Lung Cancer in Focus
Selecting Patients for Immune Checkpoint Inhibition in Lung Cancer
Clinical Advances in Hematology & Oncology August 2015, Volume 13, Issue 8 Edward B. Garon, MD Associate Clinical Professor Director, Thoracic Oncology Program Jonsson Comprehensive […]
Kidney Cancer in Focus
Lenvatinib/Everolimus Improves Survival Better Than Everolimus Alone in Metastatic Renal Cell Cancer
Clinical Advances in Hematology & Oncology August 2015, Volume 13, Issue 8 Based on a presentation by Robert Motzer, MD, at the American Society of […]
HCC In Focus
Treatment of Intermediate-Stage Hepatocellular Carcinoma
Clinical Advances in Hematology & Oncology August 2015, Volume 13, Issue 8 Richard S. Finn, MD Associate Professor of Medicine Department of Medicine, Division of […]
Clinical Update
Regorafenib in Metastatic Colorectal Cancer: Optimal Dosing and Patient Selection Recommendations
Clinical Advances in Hematology & Oncology August 2015, Volume 13, Issue 8 Axel Grothey, MD Professor of Oncology Mayo Clinic Rochester, Minnesota In the […]
Advances in LLM
Chemotherapy-Free Treatment of Acute Promyelocytic Leukemia
Clinical Advances in Hematology & Oncology August 2015, Volume 13, Issue 8 Farhad Ravandi, MD Professor of Medicine Chief of the Section of Developmental Therapeutics […]
Advances in Drug Development
Novel Drug Targets in Acute Leukemia
Clinical Advances in Hematology & Oncology August 2015, Volume 13, Issue 8 Wendy Stock, MD Professor Section of Hematology/Oncology Director, Leukemia Program University of Chicago […]
Hem/Onc News
August News
Clinical Advances in Hematology & Oncology August 2015, Volume 13, Issue 8 ASCO Updates Guidelines on Use of Hematopoietic Colony-Stimulating Factors The prophylactic use of […]